The 14 publicly traded stocks tracked by the G-2 Laboratory Index are down 4 percent for the first six months in 2008, but are up 2 percent over the past five weeks for the week ended June 20, 2008. And these lab stocks are showing better strength than the Nasdaq and S&P 500, which continue to reflect the downturned economy. The Nasdaq is down 10.03 percent and the S&P 500 is down 10.86 percent so far in 2008.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

July 2008 - Table of Contents

LIR July 2008 (full PDF issue)

Survey Finds Outreach Labs Growing at 4 Times the Rate of National Labs

Valuations Close to All-Time High; Labs Continue to Attract Private Equity Interest

Former Quest Execs Acquire New Jersey-Based Genatom and Launch Manhattan Lab

Breaking Legislative Update: House Passes Medicare Bill Repeal Competitive Bidding, Physician Fee Fix

Spectrum Labs Implements Phlebotomist Payment Collection Program

Have Rock Solid Business Infrastructure, Will Grow Pathology Business

CDC Report Assesses Lab Market, Calls for Medicare Changes

Rosetta Genomics Buys Parkway Clinical Labs for $3 Million+

Post IPO, Genoptix’s Focus Is on Growing Volume and Expanding Sales Operations

Lab Stocks Inch Upward in June, but Down 4% So Far in 2008

Sonic Healthcare to Acquire Two German Labs for Over $130 Million